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BACKGROUND: The distinction of benign from malignant mesothelial proliferations in cytologic specimens can be
problematic. In this study, the authors investigated the utility of immunohistochemical (IHC) markers in making this
distinction. METHODS: Archival paraffin-embedded cell blocks of pleural and peritoneal fluids from 52 patients with
malignant meothelioma (MM) and 64 patients with reactive mesothelial hyperplasia (MH) were retrieved. IHC stains
included desmin, epithelial membrane antigen (EMA), glucose-transport protein 1 (GLUT-1), Ki67, and p53. RESULTS:
Desmin was positive in 84% (54 of 64) cases of reactive MH and in 6% (3 of 52) of MM cases (P < .001). EMA was
positive in 9% (6 of 64) of benign and 100% (52 of 52) of malignant cases (P < .001). GLUT-1 was positive in 12% (5
of 43) of benign and 47% (7 of 15) of malignant cases. Ki67 showed strong nuclear positivity in >40% of mesothelial
cells in 9% (6 of 64) of benign and 16% (8 of 49) of malignant cases (P ¼ .38). p53 showed strong nuclear positivity
in 2% (1 of 46) of benign and 47% (7 of 15) of malignant cases (P < .001). EMA positivity and desmin negativity were
found in 2% (1 of 64) of reactive MH cases and 98% (49 of 52) of MM cases (P < .001). EMA negativity and desmin
positivity were found in 86% (55 of 64) of reactive MH cases and 0% of MM cases. CONCLUSIONS: The combination
of positive EMA and negative desmin strongly favors MM; conversely, a combination of negative EMA and positive
desmin favors a reactive process. Likewise, strong membranous positivity for GLUT-1 and/or strong nuclear staining
for p53 favors a mesothelioma. Ki67 proliferative index showed no significant difference between reactive MH and
MM cases. Cancer (Cancer Cytopathol) 2010;118:90–6. VC 2010 American Cancer Society.
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The distinction between reactive mesothelial hyperplasia (MH) and malignant mesothelioma (MM) may be very diffi-
cult based only on histologic and morphologic findings; of 217 cases circulated among all members of the US-Canadian
Mesothelioma Reference Panel, there was some disagreement about whether the process was benign or malignant in 22%
of cases.1 Frank invasion is regarded as the most important diagnostic feature of malignancy in surgical excision specimens;
however, this is not applicable to cytologic examination of effusions.1 The cytologic features commonly used to identify
malignancy, including nuclear pleomorphism, macronucleoli, large cellular aggregates, papillary-like tissue fragments,
and cell-in-cell engulfment, are helpful features but have limited use in effusion, because they may also be present in florid
reactive MH. It is well recognized that reactive MH can show various degrees of cytological atypia, and that the MM can
show very bland cytologic features.1,2
Because of the difficulty in distinguishing reactive MH from MM even in tissue specimens, such as small pleural
biopsies, several studies have used immunohistochemical markers to distinguish between reactive and neoplastic mesothe-
lial cells3-8 or between adenocarcinoma, reactive MH, and MM in serous effusions.9-14 These studies suggest that 2 of the
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most useful markers are desmin and epithelial membrane
antigen (EMA); reactive mesothelial cells have been found
to stain positive for desmin and negative for EMA,
whereas MM cells have been shown to be negative for des-
min and positive for EMA. However, these markers have
diagnostic sensitivity and specificity of <90%.8 In 1
study, glucose-transport protein 1 (GLUT-1), which is a
member of the facilitative family of glucose transporters,
was found to be positive in 100% of MMs and 0% of re-
active mesothelium; however, GLUT-1 was also found to
be positive in 96% of lung carcinomas as well.15 Others
have found that for diagnosis of MM in body cavity fluids,
GLUT-1 monoclonal and polyclonal antibodies demon-
strated a sensitivity of 40% and 67% and specificity of
95% and 74%, respectively, with a cutoff of25% of the
cells staining.14 Some studies have suggested that the pro-
liferation marker Ki67 may be useful in separating reac-
tive mesothelial proliferation from MM.16,17 The tumor
suppressor gene p53 has also been found to be overex-
pressed more frequently in MM than reactive mesothelial
proliferations, with a sensitivity ranging between 41%
and 61% and a specificity of 91%.6,8,18
These studies of immunohistochemical markers
have been mainly performed in tissue specimens, with
only rare studies performed on effusion specimens. In the
current study, we evaluate the utility of desmin, EMA,
GLUT-1, p53, and Ki67 in differentiating reactive from
MM cells in cytologic effusions and provide a comparative
analysis of their performance.
MATERIALS AND METHODS
Archival paraffin-embedded cell blocks of pleural, perito-
neal, and pericardial fluids were retrieved from the pathol-
ogy files of the University of Michigan Hospital and
University of California, San Diego Medical Center to
obtain 52 cases of MM and 64 cases of reactive MH. Only
cases with cellular cell blocks were selected. The cases of
reactive MH were confirmed with review of the previous
and/or current medical records.
The MM group of University of Michigan patients
(n ¼ 36) consisted of 24 men and 12 women with an age
range of 43 to 85 years. All of these patients had confirma-
tory histologic diagnosis, and were dead of disease, as they
were all collected over the years from either consult or
legal cases (1992-2006). The MM group of University of
California, San Diego patients (n ¼ 16) consisted of 10
men and 6 women with an age range of 46 to 89 years col-
lected from between 2001 and 2009. In this group, 2 cases
had a benign diagnosis on the initial cytologic diagnosis, 1
case had a suspicious diagnosis, and 13 had a positive
cytologic diagnosis of MM. Diagnosis of MM cases had
been previously confirmed by a panel of immunohisto-
chemical stains such as WT-1, calretinin, CK5/6, LeuM1,
and B72.3. Confirmatory surgical biopsy was available in
8 cases. All of these patients had clinical and radiological
findings consistent with mesothelioma. Clinical follow-
up showed 4 of these patients were dead of disease, 6 were
lost to follow-up, and 6 were alive with disease.
The corresponding cell blocks were cut 4 lm thick
and stained with desmin (Dako, Carpentaria, Calif; 1:100
dilution), EMA (Dako; 1:2 dilution), GLUT-1 (rabbit
polyclonal antibody, Thermo Scientific, Waltham, Mass;
1:200 dilution), p53 (Vector Laboratories, Burlingame,
Calif; 1:30 dilution), and Ki67 proliferation index (Dako,
1:100 dilution) (Table 1). The incubation and pretreat-
ment time were 30 minutes for all the immunostains.
Appropriate positive and negative controls were included.
The results for desmin immunohistochemical stains
were recorded as negative when no immunoreactivity was
seen, focal/weak if <20% of cells were positive or showed
only blush positivity, and positive if strong positivity was
seen in20% of cells. The results for EMA and GLUT-1
immunohistochemical staining were recorded as negative
(no staining), focal/weak positive if there were a few
(<20%) scattered cells that showed a membranous stain-
ing pattern or if there was only blush cytoplasmic staining
Table 1. Antibody Sources, Dilutions, and Fixation Conditions
Antibody Source Catalogue No. Dilution Fixation
Desmin Dako M0760 1:100 10% formalin
EMA Dako N1504 1:2 10% formalin
GLUT-1 Thermo Scientific RB9052 1:200 10% formalin
p53 Vector Laboratories VPp958 1:30 10% formalin
Ki67 Dako M7240 1:100 10% formalin
EMA indicates epithelial membrane antigen; GLUT-1, glucose-transport protein 1.
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but no membranous staining, and positive if there were
20% of mesothelial cells that showed strong membra-
nous accentuation and cytoplasmic staining. For Ki67,
the percentage of positive mesothelial cells was estimated
in both benign and malignant specimens and categorized
as negative (0% of nuclei staining), low (<10%), moder-
ate (10%-40%), and high (>40%). For p53, results were
recorded as negative if there was no staining or only blush
nuclear staining, focal if there was strong nuclear staining
in <10% of cells, and positive if there was strong nuclear
staining in 10% of cells. For all immunohistochemical
stains, the results were independently scored by at least 2
of the authors (F.H., G.Y.L., or C.W.M.), and any dis-
crepant cases were reviewed at a double-headed micro-
scope to achieve consensus.
Fisher exact test of statistical independence was used
for statistical analysis of comparison of reactive MH and
MM with immunohistochemical staining individually for
desmin, EMA, GLUT-1, Ki67, or p53 as well as a combi-
nation of the stains. Fisher exact test was calculated using
STATA IC10 software (StataCorp, College Station, Tex).
All tests were 2-tailed, and a P value of <.05 was consid-
ered significant.
RESULTS
The summary of results of immunohistochemical stains
used in this study is shown in Table 2. An example of a
cell block from a case of reactive MH is shown in Figure
1A and of MM in Figure 1B.
For cases of reactive MH, desmin immunohisto-
chemical staining was found to be positive (Fig. 1C) in 54
of 64 (84%) cases, focally positive in 4 of 64 cases (6%),
and negative in 6 of 64 cases (9%). For MM cases, desmin
was found to be positive in 3 of 52 (6%) cases, focally pos-
itive in 8 of 52 cases (15%), and negative (Fig. 1D) in 41
of 52 cases (79%). When using 20% of cells staining as
the cutoff, desmin had a 84% sensitivity and 94.2% speci-
ficity for separating reactive from malignant mesothelium
(P< .001).
EMA immunohistochemical staining performed on
MM cases was positive in all 52 of 52 (100%) cases. Most
cases showed strong membranous accentuation, with
some cytoplasmic staining (Fig. 1F). Only 6 of 64 (9.4%)
cases of reactive MH demonstrated strong membranous
staining for EMA. An additional 15 of 64 reactive cases
demonstrated weak or focal staining for EMA, frequently
with a blush positive cytoplasmic pattern (Fig. 1E). When
Table 2. Summary of Results of Immunohistochemical Stains
Stain Mesothelioma Reactive Sensitivity Specificity P (Fisher Exact Test)
Desmin
Negative 41 6
Focal (<20%) 8 4
Positive (‡20%) 3 54 84% 94% <.001
Total number 52 64
EMA
Negative 0 43
Focal (<20%) or weak 0 15
Positive (‡20%) 52 6 100% 91% <.001
Total number 52 64
GLUT-1
Negative to focal (<20%) 8 38
Positive (‡20%) 7 5
Total number 15 43 47% 88% .008
Ki67 proliferative index
Negative to low (<10%) 21 36
Moderate (10%-39%) 20 22 57% 56% .18
High (>40%) 8 6 16% 91% .38
Total number 49 64
p53
Negative to focal (<10%) 8 45
Positive (‡10%) 7 1
Total number 15 46 47% 98% <.001
EMA indicates epithelial membrane antigen; GLUT-1, glucose-transport protein 1.
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using membranous staining in 20% of cells as a cutoff,
it had a 100% sensitivity and 90.6% specificity (P <
.001).
GLUT-1 was interpreted as positive when it showed
a membranous staining pattern with or without cytoplas-
mic staining; however, red blood cells are normally posi-
tive for GLUT-1, rendering the interpretation of GLUT-
1 in effusion cytology difficult, particularly when the spec-
imen is contaminated by large amounts of blood. Seven of
15 (47%)MM cases were positive for GLUT-1 (Fig. 1H),
whereas 5 of 43 (12%) reactive cases were positive. For
GLUT-1 staining for MM, the sensitivity is 47%, and the
specificity is 88% (P¼ .008).
The proliferation marker Ki67 immunohistochemi-
cal staining was used to determine the proliferative index.
For MM cases, the proliferative index was high in 8 of 49
(16%) cases (Fig. 1J), moderate in 20 of 4 (41%) 9 cases,
and negative to low in 21 of 49 (43%) cases. Cellular ma-
terial was not sufficient to stain for Ki67 in 5 malignant
cases. For reactive cases, the proliferative index was high
in 6 of 64 (9%) cases, moderate in 22 of 64 (34%) cases,
and negative to low in 36 of 64 (56%) cases (Fig. 1I). One
difficulty in estimating the Ki67 labeling index in effusion
specimens is that lymphocytes in the effusion were also
frequently positive. When using moderate or greater
(10%) proliferative index as the cutoff to be considered
positive, Ki67 had 57% sensitivity and 56% specificity (P
¼ .18). When only using high Ki67 proliferative index as
a cutoff for a positive test, Ki67 had 16% sensitivity and
91% specificity (P¼ .38).
For MM, p53 immunohistochemical staining was
strongly positive in 7 of 15 (47%) cases (Fig. 1L) and focal
positive in 1 of 15 (7%) cases, whereas the remainder were
negative. For reactive mesothelial cells, p53 immunohis-
tochemical staining was positive in 1 of 46 (2%) cases and
negative in 45 of 46 (98%) cases (Fig. 1K). When using
strong positive p53 staining (10%), p53 had 47% sensi-
tivity and 98% specificity (P< .001).
Cases were analyzed for combined immunoprofile
of desmin and EMA (Table 3). For cases that were desmin
positive and EMA negative, 100% (n ¼ 55) were reactive
Figure 1. (A) An example of a cell block from a case of reac-
tive mesothelial hyperplasia is shown (H & E). (B) An example
of a cell block from a case of malignant mesothelioma is
shown (H & E). (C) Desmin: reactive mesothelial cells show
strong membranous positivity and cytoplasmic staining. (D)
Desmin: malignant mesothelial cells show no to weak and
focal staining. (E) Epithelial membrane antigen (EMA): reac-
tive mesothelial cells show no immunoreactivity. (F) EMA:
malignant mesothelial cells show strong membranous positiv-
ity and cytoplasmic staining. (G) Glucose-transport protein 1
(GLUT-1): reactive mesothelial cells show no immunoreactiv-
ity; the background positive cells are red blood cells. (H)
GLUT-1: malignant mesothelial cells show strong membranous
positivity with some cytoplasmic staining. (I) Ki67: reactive
mesothelial cells show low to scattered positive cells. (J)
Ki67: malignant mesothelial cells show strong and diffuse
positivity. (K) p53: reactive mesothelial cells show negative
to weak positivity. (L) p53: malignant mesothelial cells show
strong nuclear positivity.
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MH cases. For cases that were desmin negative and EMA
positive, 98% were MM and 2% were reactive MH (n ¼
50). For cases that were both desmin and EMA negative,
100% (n¼ 3) were reactive MH. For cases that were both
desmin and EMA positive, 37.5% were MM and 62.5%
were reactive MH (n ¼ 8). Comparison of the test results
found a significant difference (Fisher exact chi-square of
104.46, P< .0001).
Cases were also analyzed for the combined immuno-
profile of desmin, EMA, GLUT-1, and p53 (Table 4). Of
cases that had the immunophenotype of desmin positive,
EMA negative, GLUT-1 negative, and p53 negative,
100% (n¼ 34) were reactive MH. Of cases that were des-
min positive, EMA negative, GLUT-1 positive, and p53
negative, 100% (n ¼ 3) were reactive MH. Of cases that
were desmin negative, EMA positive, GLUT-1 negative,
and p53 negative, 100% (n ¼ 4) were MM. Of cases that
were desmin negative, EMA positive, GLUT-1 positive,
and p53 negative, 80% (4 of 5 cases) were MM and 20%
(1 of 5 cases) were reactive MH. Of cases that were desmin
negative, EMA positive, GLUT-1 negative, and p53 posi-
tive, 100% (n ¼ 4) were MM. Of cases that were desmin
negative, EMA positive, GLUT-1 positive, and p53 posi-
tive, 100% (n ¼ 3) were MM. Of cases that were desmin
positive, EMA positive, GLUT-1 negative, and p53 nega-
tive, 100% (n ¼ 4) were reactive MH. Of cases that were
desmin positive, EMA positive, GLUT-1 positive, and
p53 negative, 100% (n ¼ 1) were reactive MH. No cases
with the other possible combinations of stains were
observed. The comparison of the test results were signifi-
cantly different (Fisher exact chi-square of 53.83, P <
.0001).
We attempted to perform statistical analysis to
determine the best immunohistochemical panel to differ-
entiate MM from reactive MH; however; our number of
cases was insufficient.
DISCUSSION
MM is a diagnostic dilemma for the cytopathologist and
surgical pathologist because of the manymorphologic simi-
larities between neoplastic cells and their benign counter-
parts. Mesothelial cells frequently show florid reactive
changes in response tomany benign conditions such as pul-
monary infarction, systemic disease (ie, collagen-vascular
diseases), cirrhosis, radiation, underlying neoplasm,
chronic inflammation, foreign substance, and infection.
The common cytomorphologic features of mesothelial cells
in reactive effusion include increase in the cellularity of a
monomorphic cell population associated with papillary
clusters. The cells are larger than quiescent mesothelium,
with some prominence of nucleoli, regular chromatin pat-
tern, and normal nuclear to cytoplasmic ratio.19 Marked
cytologic atypia can also be seen in hyperplastic or reactive
mesothelium.2 The common cytologic features of MM
cells are nuclear pleomorphism, macronucleoli, large cellu-
lar aggregates, papillary-like tissue fragments, and cell-in-
cell engulfment, butMM cells can also be deceptively bland
and indistinguishable from benign mesothelial cells.19
Because cytologic atypia is not a reliable factor, we have
investigated a panel of immunohistochemical stains to
make this distinction in cytologic effusions.
The intermediate filament protein desmin is a
known marker for smooth and skeletal muscle differentia-
tion.20,21 Several studies have reported positive staining of
benign mesothelial cells (reactive MH) in serous fluid and
tissue sections for desmin.3-5,8,9,20 The exact etiology for
Table 3. Analysis of Results of Combined Immunoprofile of
Design and EMA
Desmin EMA Mesothelioma Reactive
Negative Negative 0 3 (100%)
Positive Negative 0 55 (100%)
Negative Positive 49 (98%) 1 (2%)
Positive Positive 3 (37.5%) 5 (62.5%)
Total number 52 64
EMA indicates epithelial membrane antigen.
Table 4. Analysis of Results of Combined Immunoprofile of Desmin, EMA, GLUT-1, and p53
Desmin EMA GLUT-1 p53 Mesothelioma Reactive
Positive Negative Negative Negative 34 (100%)
Positive Negative Positive Negative 3 (100%)
Negative Positive Negative Negative 4 (100%)
Negative Positive Positive Negative 4 (80%) 1 (20%)
Negative Positive Negative Positive 4 (100%)
Negative Positive Positive Positive 3 (100%)
Positive Positive Negative Negative 4 (100%)
Positive Positive Positive Negative 1 (100%)
EMA indicates epithelial membrane antigen; GLUT-1, glucose-transport protein 1.
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expression of desmin in mesothelial cells is not known;
however, the multipotential role of mesothelial cells with
possible muscle differentiation and coexpression of des-
min have been proposed by some studies.2,9 Our study
also confirmed cytoplasmic expression of desmin in reac-
tive mesothelial cells in 84% of cases; in contrast, only 6%
of MM cases showed expression for desmin. Our sensitiv-
ity of 84% and specificity of 94% in cytologic effusion
specimens are similar to previously reported data collected
primarily in tissue specimens. These findings suggest loss
of muscle differentiation in MM cells. Our data showed
that desmin alone is not completely a reliable marker to
differentiate between a reactive and a malignant process,
because 9% of our reactive MH cases were negative for
desmin, and 6% of our MM cases were positive, with an
additional 15% focally positive. However, it is possible
that the focal desmin staining in the mesothelioma cases
represented a residual population of non-neoplastic meso-
thelial cells.
EMA is a high molecular weight transmembranous
glycosylated protein of the breast mucin complex, which
is useful for epithelial differentiation and has been found
to be present on both carcinoma and mesothelioma
cells.8,13,19 In mesothelioma cells, EMA staining is mainly
seen on the cell surfaces, but in carcinoma cells, EMA
stains the cytoplasm of carcinoma cells. Additional immu-
nohistochemical stains should be used to differentiate me-
sothelial cells from carcinoma. It has been previously
shown that EMA stains MM cells but not reactive meso-
thelial cells with sensitivities ranging from 58% to
100%.6 All of our MM cases showed a membranous pat-
tern of staining to EMA in >20% of cells. In the 6 cases
of reactive MH that showed EMA positivity, the staining
was focal and mainly expressed as a weak membranous
pattern with blush cytoplasmic staining. Our findings are
similar to previous studies, which were primarily per-
formed in tissue specimens.5,6,7,13
GLUT-1 is a member of the mammalian facilita-
tive glucose transporters, which passively transport glu-
cose down a concentration gradient. GLUT-1 is
expressed in normal tissues, including erythrocytes, renal
tubules, and perineurium of peripheral nerves, but has
also been found in numerous carcinomas, including car-
cinomas of the lungs.15 GLUT-1 has been suggested to
be a marker for malignancy, and it has been hypothesized
that the increased expression of GLUT-1 helps maintain
energy supplies in tumor cells to allow for tumor cell sur-
vival. We found that with a rabbit polyclonal antibody, a
membrane staining pattern correlated with mesothe-
lioma; however, the sensitivity was only 47%, and the
specificity was 88%. These results are similar to those
reported in body cavity fluids by Shen et al with both
monoclonal and polyclonal antibodies, but have a much
lower sensitivity and specificity than reported in tissue
specimens by Kato et al.14,15 The difference between our
results, as well those of Shen et al, and those of Kato et al
may be related to differences in the cells that have been
exfoliated into body cavity fluids versus the cells that are
invading into tissue.
Ki67 antibodies recognize a nuclear protein
involved in the proliferative portion of the cell cycle.20
Our data indicate that a high proliferation index (>40%)
slightly favors MM, with a specificity of 91%; however,
the sensitivity is only 16.7% and is not statistically signifi-
cant (P ¼ .38). There was also no significant difference if
a proliferative index of 10% was used as the cutoff.
Other studies performed on pleural biopsies have found
that Ki67 labeling index with a cutoff of 9% labeling had
a sensitivity of 88% and specificity of 92%.17 Our results
are similar to a prior study by Schonherr et al in effusion
specimens, which used a cutoff of 26% and reported a
sensitivity of 25% and a specificity of 100%.16 It is possi-
ble that reactive mesothelial cells like any other reactive
cells show higher proliferation index. The other possibility
is contamination with many lymphocytes in the effusion
specimens, which can cause difficulty in estimating the
proliferative index by immunostain.
P53 is a 53-kDa protein product of a tumor suppres-
sor gene that regulates cell growth and inhibits cells from
entering S-phase. Mutations in p53 are common in malig-
nancies, and mutations in p53 lead to a prolonged half-
life and accumulation of high amounts of the protein. We
found that p53 staining favors a diagnosis of mesothe-
lioma, but the sensitivity is only 47%. This finding is sim-
ilar to results from studies primarily performed in tissue
specimens.6,8,18
Overall, the combination of positive EMA and neg-
ative desmin correctly identified 49 of 52 (94%) cases of
MM, whereas the combination of negative EMA and pos-
itive desmin was seen in 55 of 64 (86%) cases of reactive
MH. It is important to recognize that rare cases may
strongly coexpress both markers, and that these findings
should be interpreted in correlation with the clinical and
radiological findings. Strong and diffuse positivity for
GLUT-1 or p53 argues in favor of mesothelioma, whereas
negative findings cannot exclude mesothelioma. Ki67
proliferative index shows no significant difference
between reactive MH andMM.
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